Atlas Trials

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Clinical trial NCT01272141 · TERMINATED

Trial details

NCT number
NCT01272141
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast NeoplasmsBreast CancerCancer of the Breast
Start date
2010-12-01
Primary completion
2013-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.